TABLE 6.
Comparison of SUA in different treatment groups of severe IgAN.
| Group | P + CTX group (n = 35) | P + MMF group (n = 26) | P Group (n = 20) | Supportive treatment group (n = 17) |
|---|---|---|---|---|
| Baseline | 403.30 (358.60–488.50) | 413.05 (352.95–523.25) | 441.35 (360.00–555.67) | 504.00 (426.90–552.50) |
| The 6th month | 389.00 (330.30–494.30) | 382.30 (338.10–415.78) | 437.50 (348.50–481.75)* | 446.00 (387.00–519.25) |
| The 12th month | 386.00 (313.70–498.00) | 390.75 (345.17–412.33) | 406.00 (345.00–476.00)* | 447.00 (334.00–518.00)* |
| The 18th month | 412.90 (350.00–537.00) | 390.00 (350.58–430.90) | 405.00 (325.20–465.00) | 456.50 (411.10–517.30) |
| The 24th month | 432.65 (336.42–506.65) | 391.65 (339.30–459.10) | 428.75 (285.48–513.40) | 430.60 (324.00–504.00) |
*Compared with baseline, p < 0.05.